Investigation reveals CoFe2O4 nanoparticles effectively degrade 4-aminophenol, suggesting a promising approach for wastewater treatment.
Introduction: Industrial wastewater often contains toxic and persistent pollutants, such as phenols and nitrogen-containing derivatives like 4-aminophenol (4-AP), which are resistant to conventional treatments. Advanced oxidation processes, particularly semiconductor-based photocatalysis, offer sustainable alternatives. Objective: This study aimed to investigate the photocatalytic efficiency of CoFe2O4 nanoparticles for UV-induced degradation of 4-aminophenol (4-AP), a toxic phenolic pollutant in industrial wastewater, by correlating their structural, morphological, and optical properties with degradation performance. Methods: CoFe2O4 nanoparticles were prepared using a sol-gel method and subsequently calcined at 600°C. The structural and morphological features were analysed using XRD, FTIR, FE-SEM, and Raman spectroscopy. For photocatalytic studies, a 10-ppm solution of 4-aminophenol was exposed to UV-LED light (375 nm, 9W) under continuous stirring. At 15-minute intervals, aliquots were withdrawn, filtered, and their absorbance was measured using UV-Vis spectroscopy to assess the degradation efficiency. Results and Discussion: CoFe2O4 nanoparticles with high crystallinity, a suitable bandgap (2.65 eV), and favorable surface features exhibited strong photocatalytic activity, achieving 77% degradation of 4-AP (10 ppm) within 120 minutes using only 5 mg of catalyst under UV-LED light. The process followed pseudo-first-order kinetics (k = 0.0125 min-¹), with efficiency strongly dependent on catalyst dosage and irradiation time. Conclusion: CoFe2O4 nanoparticles demonstrated excellent potential as efficient, UV-responsive photocatalysts for degrading toxic organic pollutants like 4-aminophenol. Their tunable optical properties, high reusability, and effective performance under low-power UV-LED light make them promising candidates for sustainable and scalable wastewater treatment applications.
No takes yet. Share an insight, caveat, or question.
Shivarudraiah et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: